Showing results (191-200 of 279) with videos related to
Sort By:
Pageof 28
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.Journal of the American Heart Association|November 12, 2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertensionVanessa Fontana, Caitrin W McDonough, Yan Gong, et al.Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approachFelipe A de Oliveira, Mohamed H Shahin, Yan Gong, et al.Pharmacogenetics and Genomics|October 6, 2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazideSonal Singh, Zhiying Wang, Mohamed H Shahin, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trialEmilie Cornec-Le Gall, Jaime D Blais, Maria V Irazabal, et al.Journal of Hypertension|January 29, 2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diureticsCaitrin W McDonough, Sarah E Burbage, Julio D Duarte, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2019
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studiesMohamed H Solayman, Taimour Y Langaee, Yan Gong, et al.Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin, Kaleab Z Abebe, Arlene B Chapman, et al.Pageof 28